Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Burns

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Urology|June 16, 2023
Editorial CommentTimothy J Burns, Peter J Gilling
Anticancer Research|February 11, 2015
Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signalingTimothy J Burns, Amna Ali, Diane F Matesic
Current Bioactive Compounds|November 19, 2014
A Cell-Cell Communication Marker for Identifying Targeted Tumor TherapiesDiane F Matesic, Amna Ali, Tatyana S Sidorova, et al.
International Immunopharmacology|April 22, 2014
Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophagesJacob D Lucrezi, Timothy J Burns, Diane F Matesic, et al.
Investigational New Drugs|June 13, 2015
Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic propertiesAmna Ali, Timothy J Burns, Jacob D Lucrezi, et al.
Journal of Cellular Biochemistry|September 8, 2011
p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acidDiane F Matesic, Tatyana S Sidorova, Timothy J Burns, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Urology|June 16, 2023
Editorial CommentTimothy J Burns, Peter J Gilling
Anticancer Research|February 11, 2015
Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signalingTimothy J Burns, Amna Ali, Diane F Matesic
Current Bioactive Compounds|November 19, 2014
A Cell-Cell Communication Marker for Identifying Targeted Tumor TherapiesDiane F Matesic, Amna Ali, Tatyana S Sidorova, et al.
International Immunopharmacology|April 22, 2014
Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophagesJacob D Lucrezi, Timothy J Burns, Diane F Matesic, et al.
Investigational New Drugs|June 13, 2015
Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic propertiesAmna Ali, Timothy J Burns, Jacob D Lucrezi, et al.
Journal of Cellular Biochemistry|September 8, 2011
p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acidDiane F Matesic, Tatyana S Sidorova, Timothy J Burns, et al.
Pageof 1